眾信旅遊(002707.SZ)“眾信轉債”回售申報期為3月2日-3月6日
格隆匯3月1日丨眾信旅遊(002707.SZ)公告,關於“眾信轉債”回售。回售價格100.252元/張(含息税)。發行人資金到賬日:2020年3月11日;回售款劃撥日:2020年3月12日;投資者回售款到賬日:2020年3月13日。
行使回售權的債券持有人應在2020年3月2日至3月6日的回售申報期內通過深交所交易系統進行回售申報,回售申報當日可以撤單。回售申報一經確認,不能撤消。如果申報當日未能申報成功,可於次日繼續申報(限申報期內)。債券持有人在回售申報期內未進行回售申報,視為對本次回售權的無條件放棄。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.